USTR proposes tariffs on medical imports tied to forced labor

By AI, Created 4:22 PM UTC, June 03, 2026, /AGP/ – The U.S. Trade Representative proposed new tariffs on medical supply imports from 60 countries after finding they failed to block goods made with forced labor. The move could reshape sourcing for PPE, gloves and other critical supplies while boosting domestic manufacturers and opening a public comment fight.

Why it matters: - The proposed tariffs target foreign medical supply chains that AMMA and USTR say rely on forced labor. - The action could push buyers toward U.S. makers of PPE, gloves and other critical medical supplies. - The rule could also raise procurement costs for buyers still dependent on foreign suppliers.

What happened: - The U.S. Trade Representative on June 2 issued findings and a Federal Register notice covering 60 investigated economies. - The agency concluded all 60 economies failed to impose or effectively enforce a ban on imports produced with forced labor. - AMMA called the announcement a major advocacy victory and said the group has pushed the issue for years in Washington. - The proposed tariffs range from 10% to 12.5%. - The proposal is subject to public comments and a final administrative determination before taking effect.

The details: - 45 economies, including China, India, Vietnam, Malaysia and Thailand, face a proposed 12.5% additional tariff because they have no meaningful prohibition on forced-labor imports. - 15 economies, including Mexico, Canada and European Union members, face a proposed 10% additional tariff because they have laws on the books but are failing to enforce them. - USTR said the foreign failures burden or restrict U.S. commerce under Section 301 of the Trade Act of 1974. - USTR also said the foreign failures create unfair competition for U.S. producers in domestic and international markets. - A separate Textile Mechanism would allow a limited volume of apparel and textile imports to enter at a reduced tariff rate. - AMMA said it is working to limit that Textile Mechanism in the final rule. - The proposed tariffs would benefit makers of N95 respirators and surgical masks, where Chinese imports dominate. - Medical gowns, isolation apparel and meltblown textiles from major Asian manufacturing hubs are also likely to face the tariffs. - Makers of nitrile gloves could gain room to scale domestic production, even as procurement costs rise for buyers that still rely on imports from China, Malaysia and Thailand.

Between the lines: - The proposal reflects a broader push to link trade enforcement, labor standards and domestic industrial policy. - AMMA is trying to turn the tariff action into longer-term federal support for U.S. medical manufacturing. - AMMA President Tom Allen said the administration action validates years of advocacy and argued foreign competitors used coerced labor as a cost-cutting weapon. - AMMA Executive Director Eric Axel said the group will keep pushing for CMS payment adjustments, stronger Buy American mandates and longer federal stockpile contracts. - USTR said forced labor remains a persistent global problem that has increased in recent years. - Ambassador Jamieson Greer said the failure of major trading partners to address forced-labor imports is unacceptable and leaves American workers on an unlevel playing field.

What’s next: - June 22, 2026 is the deadline to request testimony at USTR public hearings. - July 6, 2026 is the deadline to submit written comments to the Federal Register. - USTR public hearings begin July 7, 2026. - AMMA said it will file an association-wide formal comment and is urging domestic producers to participate in the process. - AMMA is also pressing to close the Textile Mechanism loophole in the final rule.

The bottom line: - USTR’s proposal could raise costs for import-dependent buyers and strengthen the case for domestic medical manufacturing at the same time.